Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06515496 · ClinicalTrials.gov registry record · NA
A Clinical Trial to Examine the Efficacy of a Dietary Supplement to Improve the Health and Appearance of Hair.
A NA study of Hair Thinning and Hair Shedding, sponsored by Scale Media.
- Active
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06515496: Active NA study of Hair Thinning and Hair Shedding, sponsored by Scale Media.
NCT06515496 is a NA study of Hair Thinning and Hair Shedding that is active but no longer recruiting, run by Scale Media. The registered enrollment target is 100 participants, above the 56-participant average among 10 other Hair Thinning trials with a reported enrollment target (79% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06515496, a NA study of Hair Thinning and Hair Shedding, is active but no longer recruiting, sponsored by Scale Media.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the efficacy of Scale Media's HLV Clinical Formula Hair Vitamins on the health and appearance of hair, focusing on growth, volume, dullness, overall health, hair shedding, fullness, and strength. It is a randomized controlled trial with 50 female-at-birth participants experiencing self-perceived hair thinning.
Conditions Studied
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Scale HLV Clinical Formula Hair Vitamins
Study Locations (1)
California
- Citruslabs - Santa Monica
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-03-26 |
| Est. Completion | 2024-09-26 |
| Phase | NA |
What the registry record for NCT06515496 still lists
NCT06515496 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, above the 56-participant average among 10 other Hair Thinning trials with a reported enrollment target (79% higher).
The record links to 2 conditions, with Hair Thinning appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06515496 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06515496 about?
NCT06515496 is a clinical study titled "A Clinical Trial to Examine the Efficacy of a Dietary Supplement to Improve the Health and Appearance of Hair.". This study evaluates the efficacy of Scale Media's HLV Clinical Formula Hair Vitamins on the health and appearance of hair, focusing on growth, volume, dullness, overall health, hair shedding, fullness, and strength. It is a randomized controlled trial with 50 female-at-birth participants experienci...
What is the current status of trial NCT06515496?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-03-26. Estimated completion is 2024-09-26.
What conditions does trial NCT06515496 study?
This clinical trial studies the following conditions: Hair Thinning, Hair Shedding.
What interventions are being tested in trial NCT06515496?
The interventions under investigation include: Placebo (OTHER), Scale HLV Clinical Formula Hair Vitamins (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06515496?
This trial is sponsored by Scale Media, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06515496 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hair Thinning
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06515496's enrollment target sits among peer trials
100 2nd of 10 the highest of 10 other Hair Thinning trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hair Thinning trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Combined Use of Supplement and Serum in Promoting Hair Growth in Women With Self-perceived Thinning Hair
RECRUITING · NA
-
A Clinical Trial to Examine the Efficacy of a Supplement to Support Healthy Hair and Skin
ACTIVE NOT RECRUITING · NA
-
Efficacy and Safety of TargetCool + Benev Exosomes in Patients With Hair Thinning
ACTIVE NOT RECRUITING · NA
-
The Effects of an Oral Hair Supplement on Hair Density, Growth, and Microbiome
ACTIVE NOT RECRUITING · NA
-
Efficacy and Safety of a Nutraceutical Supplement With Standardized Botanicals in Women With Thinning Hair
COMPLETED · NA
-
A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Female Subjects With Hair Loss
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI